FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial

FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial This is a developing news story. Please check back for updates: https://www.cnbc.com/2023/01/06/alzheimers-disease-fda-decision-on-biogen-eisai-treatment-lecanemab.html Follow @CNBCnow for breaking news and real-time market updates Unsubscribe Manage Newsletters Terms of Service Join the CNBC Panel   Digital Products Feedback Privacy Policy CNBC Events   © 2023 CNBC LLC. All rights reserved. A property of NBCUniversal. 900 Sylvan Avenue, Englewood Cliffs, NJ 07632 Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes and Market Data and Analysis. Data also provided by THOMSON REUTERS